Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States : a systematic review and meta-analysis
INTRODUCTION: Although frailty is common among community-dwelling older adults, its prevalence in Europe and how this varies between countries is unclear.
METHODS: A systematic review and meta-analysis of literature on frailty prevalence in 22 European countries involved in the Joint Action ADVANTAGE was conducted.
RESULTS: Sixty-two papers, representing 68 unique datasets were included. Meta-analysis showed an overall estimated frailty prevalence of 18% (95% confidence interval, CI, 15-21%). The prevalence in community (n = 53) vs non-community based studies (n = 15) was 12% (95% CI 10-15%) and 45% (95% CI 27-63%), respectively. Pooled prevalence in community studies adopting a physical phenotype was 12% (95% CI 10-14%, n = 45) vs 16% (95% CI 7-29%, n = 8) for all other definitions. Sub-analysis of a subgroup of studies assessed as high-quality (n = 47) gave a pooled estimate of 17% (95% CI 13-21%).
CONCLUSIONS: The considerable and significant heterogeneity found warrants the development of common methodological approaches to provide accurate and comparable frailty prevalence estimates at population-level.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
---|---|
Enthalten in: |
Annali dell'Istituto superiore di sanita - 54(2018), 3 vom: 22. Juli, Seite 226-238 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
O'Caoimh, Rónán [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.02.2019 Date Revised 10.04.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.4415/ANN_18_03_10 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM289200687 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM289200687 | ||
003 | DE-627 | ||
005 | 20231225062027.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4415/ANN_18_03_10 |2 doi | |
028 | 5 | 2 | |a pubmed24n0963.xml |
035 | |a (DE-627)NLM289200687 | ||
035 | |a (NLM)30284550 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a O'Caoimh, Rónán |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States |b a systematic review and meta-analysis |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.02.2019 | ||
500 | |a Date Revised 10.04.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Although frailty is common among community-dwelling older adults, its prevalence in Europe and how this varies between countries is unclear | ||
520 | |a METHODS: A systematic review and meta-analysis of literature on frailty prevalence in 22 European countries involved in the Joint Action ADVANTAGE was conducted | ||
520 | |a RESULTS: Sixty-two papers, representing 68 unique datasets were included. Meta-analysis showed an overall estimated frailty prevalence of 18% (95% confidence interval, CI, 15-21%). The prevalence in community (n = 53) vs non-community based studies (n = 15) was 12% (95% CI 10-15%) and 45% (95% CI 27-63%), respectively. Pooled prevalence in community studies adopting a physical phenotype was 12% (95% CI 10-14%, n = 45) vs 16% (95% CI 7-29%, n = 8) for all other definitions. Sub-analysis of a subgroup of studies assessed as high-quality (n = 47) gave a pooled estimate of 17% (95% CI 13-21%) | ||
520 | |a CONCLUSIONS: The considerable and significant heterogeneity found warrants the development of common methodological approaches to provide accurate and comparable frailty prevalence estimates at population-level | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
700 | 1 | |a Galluzzo, Lucia |e verfasserin |4 aut | |
700 | 1 | |a Rodríguez-Laso, Ángel |e verfasserin |4 aut | |
700 | 1 | |a Van der Heyden, Johan |e verfasserin |4 aut | |
700 | 1 | |a Ranhoff, Anette Hylen |e verfasserin |4 aut | |
700 | 1 | |a Lamprini-Koula, Maria |e verfasserin |4 aut | |
700 | 1 | |a Ciutan, Marius |e verfasserin |4 aut | |
700 | 1 | |a López-Samaniego, Luz |e verfasserin |4 aut | |
700 | 1 | |a Carcaillon-Bentata, Laure |e verfasserin |4 aut | |
700 | 1 | |a Kennelly, Siobhán |e verfasserin |4 aut | |
700 | 1 | |a Liew, Aaron |e verfasserin |4 aut | |
700 | 0 | |a Work Package 5 of the Joint Action ADVANTAGE |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annali dell'Istituto superiore di sanita |d 1967 |g 54(2018), 3 vom: 22. Juli, Seite 226-238 |w (DE-627)NLM000417572 |x 2384-8553 |7 nnns |
773 | 1 | 8 | |g volume:54 |g year:2018 |g number:3 |g day:22 |g month:07 |g pages:226-238 |
856 | 4 | 0 | |u http://dx.doi.org/10.4415/ANN_18_03_10 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 54 |j 2018 |e 3 |b 22 |c 07 |h 226-238 |